- Home
- RDI vs LTRN Comparison
RDI vs LTRN Comparison
Compare RDI & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDI
- LTRN
- Stock Information
- Founded
- RDI 1937
- LTRN 2013
- Country
- RDI United States
- LTRN United States
- Employees
- RDI N/A
- LTRN N/A
- Industry
- RDI Movies/Entertainment
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- RDI Consumer Discretionary
- LTRN Health Care
- Exchange
- RDI Nasdaq
- LTRN Nasdaq
- Market Cap
- RDI 35.7M
- LTRN 36.0M
- IPO Year
- RDI N/A
- LTRN 2020
- Fundamental
- Price
- RDI $1.53
- LTRN $4.07
- Analyst Decision
- RDI
- LTRN Strong Buy
- Analyst Count
- RDI 0
- LTRN 1
- Target Price
- RDI N/A
- LTRN $25.00
- AVG Volume (30 Days)
- RDI 55.7K
- LTRN 111.9K
- Earning Date
- RDI 11-13-2025
- LTRN 11-06-2025
- Dividend Yield
- RDI N/A
- LTRN N/A
- EPS Growth
- RDI N/A
- LTRN N/A
- EPS
- RDI N/A
- LTRN N/A
- Revenue
- RDI $219,213,000.00
- LTRN N/A
- Revenue This Year
- RDI $5.21
- LTRN N/A
- Revenue Next Year
- RDI $11.45
- LTRN N/A
- P/E Ratio
- RDI N/A
- LTRN N/A
- Revenue Growth
- RDI 7.59
- LTRN N/A
- 52 Week Low
- RDI $1.17
- LTRN $2.55
- 52 Week High
- RDI $1.88
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- RDI 56.79
- LTRN 48.14
- Support Level
- RDI $1.47
- LTRN $3.85
- Resistance Level
- RDI $1.60
- LTRN $4.34
- Average True Range (ATR)
- RDI 0.07
- LTRN 0.29
- MACD
- RDI -0.01
- LTRN -0.02
- Stochastic Oscillator
- RDI 42.86
- LTRN 45.93
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.